Sony DADC and Maven Biotechnologies to Develop Smart Consumables for Novel Label-Free Detection
Sony DADC BioSciences and Maven Biotechnologies today announced a collaboration to develop and manufacture smart consumables for Maven’s LFIRE™ detection platform.
LFIRE™ stands for Label-Free Internal Reflection Ellipsometry. It is a flexible and cost-effective, real-time imaging technology for performing cell-based assays and multiplexed biomarker detection. In 2010, the National Institute of Health (NIH) awarded Maven a $1.96 million grant to commercialize the technology.
“The collaboration with Maven provides a perfect example of how we can translate our experience in micro-structured engineering, gained through our pioneering optical disc work, to the needs of the life sciences industry,” says Ali Tinazli Ph.D., Director of Business Development & Sales North America of Sony DADC. “We are particularly pleased to work with Maven at such an early stage, which ensures solutions that will be scalable and traceable, to smooth the way to future regulatory approvals in the clinical space. The product is an advanced polymer slide that can be produced in mass quantities and still guarantee high optical quality.”
Jeffrey Chongsathien, Maven’s Chief Engineering Officer said "We are excited to be working with Sony DADC to develop innovative consumables for our LFIRE™ platform. With Sony DADC's expertise in creating highly scalable and sophisticated optical media, we ensure that our customers will receive the maximum benefits of using LFIRE™ technology and at a lower cost per data point."
Claudia Lee Ph.D., Head of Biophysics R&D, added "The high quality molding and optical coating expertise provided by Sony DADC is essential to the realization of the Maven consumable. Furthermore, the complimentary interaction with their engineering experts has stimulated innovative technology development at Maven."
About Maven Biotechnologies
Maven Biotechnologies is a privately-held life science tools company located in Monrovia, CA USA. The company has developed LFIRE™ [pronounced: el – fire] – a flexible and cost-effective, real-time imaging technology for performing quantitative, label-free cell-based assays and sensitive multiplexed biomarker detection. The platform addresses applications in biomedical research, drug discovery, biological manufacturing and immunodiagnostics. Maven holds 23 granted patents.
For more information please visit www.mavenbiotech.com.
About Sony DADC BioSciences
Sony DADC is a leading disc and digital service provider for the entertainment, education and information industries, offering world-class digital and physical supply chain solutions and software services. Building on the company’s experience in high-precision manufacturing, its mass production capability and supply chain expertise, Sony DADC’s BioSciences division partners with Life Sciences, Medical Technologies and Diagnostics companies enabling the industrial manufacturing of smart consumables. Sony DADC’s global set-up comprises production sites, distribution hubs, digital & service facilities in 19 countries worldwide, including Japan, the US and Europe.
For more information please visit www.sonydadc.com.
William R. Rassman
MD - Founder and CEO
+1 (310) 505 5383
+43 6246 880 281